← Evidence map

ArticleACS central science2023

Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro.

Ningke Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

41 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36844503